JP2022525925A5 - - Google Patents
Info
- Publication number
- JP2022525925A5 JP2022525925A5 JP2021556481A JP2021556481A JP2022525925A5 JP 2022525925 A5 JP2022525925 A5 JP 2022525925A5 JP 2021556481 A JP2021556481 A JP 2021556481A JP 2021556481 A JP2021556481 A JP 2021556481A JP 2022525925 A5 JP2022525925 A5 JP 2022525925A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- modified
- chain
- functional fragment
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819988P | 2019-03-18 | 2019-03-18 | |
| US62/819,988 | 2019-03-18 | ||
| PCT/IB2020/000140 WO2020188348A2 (en) | 2019-03-18 | 2020-03-17 | A2/ny-eso-1 specific t cell receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525925A JP2022525925A (ja) | 2022-05-20 |
| JP2022525925A5 true JP2022525925A5 (enExample) | 2023-03-17 |
| JP7680032B2 JP7680032B2 (ja) | 2025-05-20 |
Family
ID=70465122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556481A Active JP7680032B2 (ja) | 2019-03-18 | 2020-03-17 | Ａ２／ｎｙ－ｅｓｏ－１特異的ｔ細胞受容体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12473346B2 (enExample) |
| EP (1) | EP3941939A2 (enExample) |
| JP (1) | JP7680032B2 (enExample) |
| CN (1) | CN113906140B (enExample) |
| AU (1) | AU2020243431B2 (enExample) |
| CA (1) | CA3134102A1 (enExample) |
| WO (1) | WO2020188348A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| WO2022067005A1 (en) * | 2020-09-27 | 2022-03-31 | Genentech, Inc. | High throughput multiparametric immune cell engager screening assay |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| US20240207319A1 (en) | 2021-05-06 | 2024-06-27 | Ludwig Institute For Cancer Research Ltd | Compositions and methods for immunotherapy |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| EP4374872A1 (en) * | 2022-11-22 | 2024-05-29 | Koninklijke Philips N.V. | Pde enhanced car-t cells |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000078334A1 (en) | 1999-06-17 | 2000-12-28 | University Of Maryland Biotechnology Institute | Chimeric chemokine-antigen polypeptides and uses therefor |
| IL160359A0 (en) | 2001-08-31 | 2004-07-25 | Avidex Ltd | Soluble t cell receptor |
| AU2005246073B2 (en) | 2004-05-19 | 2010-10-28 | Adaptimmune Limited | Method of improving T cell receptors |
| ATE417065T1 (de) | 2004-05-19 | 2008-12-15 | Medigene Ltd | Hochaffiner ny-eso-t-zellen-rezeptor |
| US9963510B2 (en) | 2005-04-15 | 2018-05-08 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
| ES2971647T3 (es) | 2005-04-15 | 2024-06-06 | Macrogenics Inc | Diacuerpos covalentes y usos de los mismos |
| US8088379B2 (en) * | 2006-09-26 | 2012-01-03 | The United States Of America As Represented By The Department Of Health And Human Services | Modified T cell receptors and related materials and methods |
| WO2008037943A1 (en) | 2006-09-29 | 2008-04-03 | Medigene Limited | Cells transformed with nucleic acid encoding ny-eso t cell receptors |
| CA2700278A1 (en) * | 2007-09-25 | 2009-04-02 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Modified t cell receptors and related materials and methods |
| GB0908613D0 (en) | 2009-05-20 | 2009-06-24 | Immunocore Ltd | T Cell Reseptors |
| ES2816647T3 (es) | 2012-01-17 | 2021-04-05 | Univ Leland Stanford Junior | Reactivos SIRP-alfa de alta afinidad |
| CN113684185A (zh) | 2013-02-26 | 2021-11-23 | 纪念斯隆-凯特琳癌症中心 | 用于免疫疗法的组合物和方法 |
| US20170335331A1 (en) | 2014-10-31 | 2017-11-23 | The Trustees Of The University Of Pennsylvania | Altering Gene Expression in CART Cells and Uses Thereof |
| US20210206826A1 (en) * | 2015-11-19 | 2021-07-08 | The Regents Of The University Of California | Conditionally repressible immune cell receptors and methods of use thereof |
| GB201522592D0 (en) | 2015-12-22 | 2016-02-03 | Immunocore Ltd | T cell receptors |
| GB201616238D0 (en) | 2016-09-23 | 2016-11-09 | Adaptimmune Ltd | Modified T cells |
| CN108456247A (zh) * | 2017-02-20 | 2018-08-28 | 上海恒润达生生物科技有限公司 | 靶向ny-eso-1的t细胞受体及其用途 |
-
2020
- 2020-03-17 CN CN202080031738.8A patent/CN113906140B/zh active Active
- 2020-03-17 CA CA3134102A patent/CA3134102A1/en active Pending
- 2020-03-17 EP EP20721721.7A patent/EP3941939A2/en active Pending
- 2020-03-17 JP JP2021556481A patent/JP7680032B2/ja active Active
- 2020-03-17 US US17/440,136 patent/US12473346B2/en active Active
- 2020-03-17 AU AU2020243431A patent/AU2020243431B2/en active Active
- 2020-03-17 WO PCT/IB2020/000140 patent/WO2020188348A2/en not_active Ceased
-
2025
- 2025-10-17 US US19/361,931 patent/US20260103503A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525925A5 (enExample) | ||
| CN110818802B (zh) | 一种嵌合t细胞受体star及其应用 | |
| CN106459990B (zh) | 三功能t细胞抗原偶联物及其制备方法和用途 | |
| CN109575143B (zh) | 双特异性cd20-cd19-car及其应用 | |
| JP2023052263A (ja) | 腫瘍形質導入のための組成物及び方法 | |
| CN113698490B (zh) | 靶向cea的缺氧诱导启动的car结构及免疫细胞和应用 | |
| US11878035B2 (en) | T cell-antigen coupler with various construct optimizations | |
| CN110616191B (zh) | 共刺激配体联合的car t疗法 | |
| CN110357952B (zh) | 识别人乳头瘤病毒hpv16-e7抗原的tcr | |
| JP7404279B2 (ja) | 様々な構築物最適化を備えたｔ細胞抗原カプラ | |
| CN108138148A (zh) | T细胞的激活和扩增 | |
| WO2024119769A9 (zh) | 增强向肿瘤部位浸润能力的car-nk细胞制备及应用 | |
| CN111019905A (zh) | Car修饰细胞及其在制备自身免疫性疾病药物中的应用 | |
| JP2021501567A (ja) | Ｙ１８２ｔ突然変異を有するｔ細胞−抗原カプラおよびその方法ならびに使用 | |
| JP2023528255A5 (enExample) | ||
| CN103965362A (zh) | 一种可使t细胞趋向肿瘤部位的嵌合趋化因子受体 | |
| WO2023010068A2 (en) | Multiprotein-engineered cells secreting a multispecific antibody | |
| WO2021190551A1 (zh) | 结合cd19的嵌合抗原受体及其用途 | |
| CN114555815A (zh) | T细胞受体及其使用方法 | |
| CN111499766B (zh) | 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用 | |
| CN116490518A (zh) | 用于重定向免疫抑制信号传导的嵌合MyD88受体及相关组合物和方法 | |
| KR20220038776A (ko) | T 세포 수용체 및 이의 사용 방법 | |
| KR20220040489A (ko) | T 세포 수용체 및 이의 사용 방법 | |
| CN113929767B (zh) | 具有高亲和力的t细胞受体及其用途 | |
| CN121319150B (zh) | 一种同时识别hbv核心抗原表位及包膜蛋白表位的tcr及其编码序列 |